June 10, 2024 Three MIP Students Named 2024-25 VPR Graduate Fellows

Diana Lowe (Telling lab), Elena Lian (Jackson lab) and Jebrail Dempsey (Hemming-Schroeder & Foy labs), were each awarded a 2024-25 VPR Graduate fellowship.
August 11, 2022 Drug Discovery News: An antimalarial drug targets bacterial infections

Antimalarial drugs show potential for treating chronic lung infections caused by Mycobacterium abscessus, which would improve the quality of life for patients with limited treatment options.
January 14, 2022 RCF Radio: La lèpre n’attire pas les financements pour la recherche [French]

Mary Jackson joined the Conviction et Engagement Avec la Fondation Raoul-Follereau podcast to discuss state of funding for leprosy research.
March 9, 2021 Reflecting on research: A year of COVID-19 at CSU

Using the only approved TB vaccine, Mary Jackson and her research team are developing a novel COVID-19 vaccine candidate.
March 8, 2021 Female Researchers at Colorado State University are Taking a Lead to Combat COVID-19

On International Women’s Day, CSU celebrate the contributions and impact of women everywhere.
March 3, 2021 Racing to save humans through animal research

Animal research, including adaption of an existing TB vaccine, greatly contribute to the understanding of and response to SARS-COV-2.

February 22, 2021 CSU vaccine research advances, groundwork begins to develop coronavirus vaccine for the next pandemic

CSU infectious disease scientists are continuing efforts on four unique projects to develop a possible COVID-19 vaccine.
May 19, 2020 ‘We have to try it’: Tuberculosis expert explores coronavirus vaccine research

A research team led by Mary Jackson are investigating if the BCG vaccine platform can effectively fight COVID-19.
June 29, 2018 New evidence that wild armadillos spread leprosy to humans

A CSU-led international team has indentified that contact with armadillos resulted in high Mycobacterium leprae infection rates.
1 2